Loading...

Wuhan General Group (China), Inc.

WUHN•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Wuhan General Group (China), Inc. (WUHN) Company Profile & Overview

Explore Wuhan General Group (China), Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Wuhan General Group (China), Inc. (WUHN) Company Profile & Overview

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOJeffrey Robinson

Contact Information

https://wuhn.org
514-928-7368
6500 Transcanada hwy, Pointe-Claire, QC, H9R 0A5

Company Facts

700 Employees
IPO DateApr 19, 2006
CountryCA
Actively Trading

Frequently Asked Questions

;